ArticleLeukemia & lymphoma2018

Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study.

Zanetta S Lamar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.